Seeking Alpha

Amarin Corporation (AMRN +0.5%) says it's submitted a Supplemental New Drug Application to the...

Amarin Corporation (AMRN +0.5%) says it's submitted a Supplemental New Drug Application to the FDA seeking approval for BASF (BASFY.PK) as an additional Vascepa active pharmaceutical ingredient supplier.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector